Ardea Biosciences Appoints John W. Beck Chief Financial Officer

In the office.
And on the beach

The web magazine for top managers - who's promoted, who came, who left? And what to do when you're not in the office.

May 9, 2008, San Diego, Ca., USA - Ardea Biosciences, Inc. announced that John W. Beck has been appointed Senior Vice President, Finance and Operations and Chief Financial Officer, effective May 27, 2008.

Mr. Beck received a B.A. in accounting from the University of Washington and also holds a Th.B. in theology from a Seattle, Washington-based seminary. Mr. Beck is a licensed certified public accountant in the state of California and is a member of the American Institute of Certified Public Accountants and the Association of Bioscience Financial Officers. Mr. Beck held financial management positions at various high technology and financial services companies, including General Dynamics and Ernst and Young LLP. Mr. Beck served as Director of Finance of Neurocrine Biosciences, Inc., where he played an important role in Neurocrine's 1996 initial public offering. Mr. Beck joins Ardea Biosciences from Metabasis Therapeutics, Inc., which he co-founded in 1999 and where he served most recently as Senior Vice President of Finance, Chief Financial Officer and Treasurer.

Post to:

Enjoy more articles from this section

BusinessWeek Investing News

Stocks: More Doldrums Ahead
Rising unemployment and inflation have market watchers taking back predictions of a second-half rally
Wed, 2 Jul 2008 22:17:00 EDT

Ruined by 401(k) Predators
Retirees with plump nest eggs can be targets for unscrupulous financial advisers who rake in hefty fees with promises of huge returns
Wed, 2 Jul 2008 23:14:00 EDT

Trouble Brewing for Craft Beer Makers
Microbrewers are dealing with rising commodity prices and a slowing economy by raising prices and consolidating
Thu, 3 Jul 2008 22:01:00 EDT

In the office.
And on the beach